LAWRENCE DAVID 4
4 · ACORDA THERAPEUTICS INC · Filed Nov 12, 2019
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-11-07+80,000→ 80,000 totalExercise: $2.41Exp: 2029-11-07→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Options issued under the issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to the options vest in equal quarterly installments over two years beginning on November 7, 2019 with the first quarterly installment vesting on February 7, 2020.